Despite extensive experience in administering a wide range of immune therapies in the home setting, cancer-related treatments have been slower to migrate to the home setting. Hear from clinicians and payors who have developed programs to address the unique needs of cancer patients receiving treatment at home.
Despite extensive experience in administering a wide range of immune therapies in the home setting, cancer-related treatments have been slower to migrate to the home setting. Hear from clinicians and payors who have developed programs to address the unique needs of cancer patients receiving treatment at home.
Learning Objectives
Identify the driving forces behind the increase in oncology and immunotherapy in the home setting.
Review the most common therapies provided in the home setting.
Identify aspects from payors regarding oncology in the home.